AAV9: a potential blood-brain barrier buster

FP Manfredsson, AC Rising, RJ Mandel - Molecular Therapy, 2009 - cell.com
… Figure 1Schematic of potential AAV access to the CNS from the periphery. (a) Retrograde
AAV9 receptors. Several candidates are depicted, but this is not a complete list of possible

AAV9: over the fence and into the woods…

JR Forsayeth, KS Bankiewicz - Molecular Therapy, 2011 - cell.com
… of AAV vector serotypes, AAV9. These new reports complement recent articles published in
MT and elsewhere suggesting that AAV9 … by rAAV9 trans-blood-brain barrier gene delivery. …

An Induced Pluripotent Stem Cell-Derived Human BloodBrain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense …

J Selvakumaran, S Ursu, M Bowerman, N Lu-Nguyen… - Biomedicines, 2023 - mdpi.com
… for AAV9, we further compared AAV8 and AAV9AAV9 crossing at 72 h revealed that 5.3
× 10 6 vg AAV9 crossed the 4603-derived BBB while only 1.1 × 10 6 vg of AAV8 crossed. AAV9

AAV9 transduction mediated by systemic delivery of vector via retro-orbital injection in newborn, neonatal and juvenile mice

S Prabhakar, S Lule, CC Da Hora… - Experimental …, 2021 - jstage.jst.go.jp
… ROI as an effective route of AAV delivery, herein we aim to … Cre reporter mice) with the AAV9
vector, which targets a wide … aaV9: a potential blood-brain barrier buster. Mol Ther. 2009; …

Protein LY6E as a candidate for mediating transport of adeno-associated virus across the human blood-brain barrier

AM Ille, E Kishel, R Bodea, A Ille, H Lamont… - Journal of …, 2020 - Springer
… In furthering this exploration, we report the novel identification of human LY6E as a potential
mediator of AAV BBB transcytosis. Moreover, our computational analysis of the proposed …

Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1

RJ Chandler, IM Williams, AL Gibson… - Human molecular …, 2017 - academic.oup.com
… established that certain adeno-associated virus (AAV) serotypes, such as 9 and rh10, possess
an inherent capability to cross the blood-brain barrier and to transduce cells in the central …

Arming AAV9 with a Single-Chain Fragment Variable Antibody Against PD-1 for Systemic Glioblastoma Therapy

S Maksoud, MW Schweiger, EI Tabet, T Xiao… - Molecular …, 2024 - Springer
… For instance, AAV serotype 9 (AAV9) can cross the bloodbrain barrier (BBB) and, as a …
of an AAV9 vector engineered to express a single-chain scFv antibody against PD-1 (AAV9-scFv-…

Non-invasive Delivery to the Inner Ear: Investigating Blood-Labyrinth Barrier Opening Using MRI-Guided Focused Ultrasound Combined with Microbubbles

N Chauhan - 2021 - search.proquest.com
AAV variants, such as the synthetic AAV-inner ear (AAV-ie) … AAVie efficiently transduced all
cochlear SCs, and after AAV-ie… , and is equivalent to that of the blood-brain barrier (BBB) 15. …

Global CNS transduction of adult mice by intravenously delivered rAAVrh. 8 and rAAVrh. 10 and nonhuman primates by rAAVrh. 10

B Yang, S Li, H Wang, Y Guo, DJ Gessler, C Cao… - Molecular Therapy, 2014 - cell.com
… (rAAVs) can cross the neonatal bloodbrain barrier (BBB) and efficiently transduce cells of
… CNS transduction is a common character of AAV serotypes tested. Of note, rAAVrh.8 is the …

Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs

T Federici, JS Taub, GR Baum, SJ Gray, JC Grieger… - Gene therapy, 2012 - nature.com
… 9 (AAV9) has recently been shown to penetrate the bloodbrain barrier via intravascular …
However, the potential side effects of systemic delivery are unknown. Intrathecal viral vector …